Asuragen is a molecular diagnostic company changing the way patients are treated in genetics and oncology. The quality, sensitivity and simplicity of our products are key to delivering true precision medicine. The company’s diagnostic systems, composed of proprietary chemistries and software, deliver powerful answers using widely available platforms. Asuragen’s approach starts by identifying a clinical need, where the lives of millions of patients can be impacted with the availability of complex molecular tests for diseases that are difficult to diagnosis and/or monitor. Asuragen is a product foundry rapidly addressing these significant current and emerging clinical needs with best-in-class diagnostic kits.
Location: United States, Texas, Austin
Employees: 201-500
Phone: +1 512-681-5200
Founded date: 2006
Investors 1
| Date | Name | Website |
| - | Telegraph ... | thpartners... |
Mentions in press and media 11
| Date | Title | Description | Source |
| 04.01.2022 | Asuragen to Host “Advances in Practical, Broad Coverage CFTR... | Asuragen to Host “Advances in Practical, Broad Coverage CFTR Testing with the AmplideX® PCR/CE CFTR ... | prweb.com/... |
| 07.07.2020 | Asuragen Announces CE Mark of AmplideX® SMA Plus Kit | The assay is intended to aid in the diagnosis of and identification of carriers for spinal muscular ... | thpartners... |
| 05.09.2018 | Asuragen Expands Oncology Portfolio with CE Marking and Laun... | The panel accurately and sensitively detects over 1600 variants of clinical significance AUSTIN, Te... | thpartners... |
| 17.01.2018 | Asuragen Obtains CE Mark of QuantideX® qPCR BCR-ABL Kits on ... | AUSTIN, Texas– Asuragen, Inc., a global molecular diagnostics product company changing the way patie... | thpartners... |
| 10.12.2014 | Three new biomarker companies selected to work with Abcodia ... | Three new biomarker companies selected to work with Abcodia and the Early Cancer Consortium 10-12-20... | cambridgen... |
| 24.10.2012 | MicroRNA-based cancer therapy firm scoops up $34.5 million, ... | Solution/product: Mirna develops cancer therapies based on tumor suppressor microRNAs, which regain ... | medcitynew... |
| 08.08.2012 | Cancer diagnostics company using genomics analysis raising $... | Location: Pittsburgh, Pennsylvania. Solution/product: The biotechnology company uses genomics analys... | medcitynew... |
| 03.04.2008 | Life-science briefing: Thursday, April 3, 2008 | TODAY’S HEADLINES: Mirna Thera spins out of Asuragen with $3M (release) Stroke-therapy startup CoAxi... | venturebea... |
| 10.12.2007 | Life sciences briefing: Monday, Dec. 10, 2007 | TODAY’S HEADLINES: Fundamental Applied Biology pulls in $21M for proteins without cells (release) Di... | venturebea... |
| - | MicroRNA-based cancer therapy firm scoops up $34.5 million, ... | Company name: Mirna Therapeutics. Industry: biopharmaceuticals. Location: Austin, Texas. Solution/pr... | medcitynew... |
Show more